TMC207 CAS 843663-66-1 Kuchena > 99.5% (HPLC)

Tsanangudzo Pfupi

Zita: TMC207

Mashoko anoreva zvakafanana: R207910

CAS: 843663-66-1

Kuchena:> 99.5% (HPLC)

Chitarisiko: White kana Off-White Powder

API, High Quality, Commercial Production

Nharembozha/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name TMC207
Mashoko anoreva zvakafanana TMC-207, R207910;Sirturo;(αS,βR) -6-Bromo-α--[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-Quinolineethanol;1-(6-Bromo-2-methoxyquinolin-3-yl)-4-dimethylamino-1-phenyl-2-(1-naphthyl) 2-butanol
Nhamba yeCAS 843663-66-1
Nhamba yeCAT RF2336
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C32H31BrN2O2
Molecular Weight 555.516
Melting Point 104℃
Density 1.322±0.06 g/cm3
Sensitive Hygroscopic.Chiedza Sensitive, Mhepo Inonzwa
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko White kana Off-White Powder
Kuchena / Analysis Method >99.5% (HPLC)
Kurasika paKuomesa <0.50%
Residue paIgnition <0.20%
Chero Kusachena Kwemunhu <0.10%
Isomer <0.10%
Zvose Zvisina Kuchena <0.50%
Heavy Metals (as Pb) <20ppm
Arsenic (As) <2.0ppm
Infrared Spectrum Inopindirana neChimiro
Proton NMR Spectrum Inopindirana neChimiro
Test Standard Enterprise Standard
Usage API

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

Yakakwana Capacity: Inokwana zvivakwa uye matekiniki

Professional Service: Imwe inomira kutenga sevhisi

OEM Package: Tsika pasuru uye label iripo

Fast Delivery: Kana iri mukati me stock, mazuva matatu ekutumira anovimbiswa

Yakagadzika Supply: Chengetedza zvine musoro stock

Tsigiro yehunyanzvi: Tekinoroji mhinduro iripo

Tsika Synthesis Service: Kubva pamagiramu kusvika makirogiramu

Hunhu Hwepamusoro: Yakagadzira yakakwana yemhando yekusimbisa system

FAQ:

Kutenga sei?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com 

Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.

Main Markets?Inonyanya kutumirwa kuNorth America, India, Russia, Korea, Japan, uye Europe, nezvimwe.

HunhuSimbiso?Kuvimbika kuvimbiswa kwehutano, kutonga kwakasimba.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.

Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.

Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.

MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.

Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.

Transportation?Ne Express (FedEx, DHL), neMhepo, negungwa.

Custom Synthesis?Inogona kupa tsika synthesis masevhisi.

Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.

Application:

(CAS: 843663-66-1), (inozivikanwa se TMC207 uye R207910), inotengeswa pasi pezita rekutengeserana rinonzi Sirturo, inoveli diarylquinoline antimycobacterial drug inobata tuberculosis nekudzivisa basa reM. tuberculosis ATP synthase proton pump.Iyo ATP synthesis ye mycobacteria inoshandisa antibacterial uye bactericidal mhedzisiro.Clinically inoshandiswa kurapa vanhu vakuru multidrug-resistant tuberculosis (MDR-PTB).TMC207 ine utachiona hwakafanana hwekurwisa M. tuberculosis twumhando uye twusingarambiki, uye inewo kunaka kwekuuraya utachiona pamabhakitiriya akarara.Muna Zvita 2012, US FDA yakabvumidza TMC207 sechikamu chemusanganiswa wekurapa kwechirwere cherurindi chisingarambiri zvinodhaka (MDRTB).TMC207 ndiwo mushonga wekutanga kubvumirwa MDR-TB uye ndiyo mvumo yekutanga kubva kuchikwata chitsva chemishonga yekurwisa tibhii mumakore makumi mana apfuura.Nekuda kwekunyanya kudiwa kwekurapa MDR-TB, FDA yakapa TMC207 mvumo yekukurumidza zvichibva pamhedzisiro yeChikamu chechipiri, ichipa varwere mukana wekuwana mushonga apo zvimwe zvidzidzo zvekiriniki zvichiitwa.TMC207 idiarylquinoline yakawanikwa kubva muchirongwa chepamusoro-soro, chekuongorora-sero-sero neMycobacterium smegmatis yakashandiswa seyakatsiva M. tuberculosis.TMC207 ndeye imwe enantiomer yekutanga yekutarisa hit.TMC207 ine simba uye inosarudza kurwisa mycobacteria, uye inoshanda kurwisa zvese zviri zviviri zvinodhaka uye zvisingaite mushonga M. tuberculosis.Nzira yekuita kweTMC207 yakasiyana pakati pemishonga inorwisa TB uye inosanganisira kuvharidzirwa kwemycobacterial ATP synthase;haisi kushanda inopesana nevanhu ATP synthase.TMC207 ine in vivo chiitiko mune akawanda preclinical modhi yehutachiona hweTB, yega uye yakabatana nemamwe anti-TB agent, uye ine hutachiona hwehutachiona mumhando dzakatangwa dzehutachiona hweTB.TMC207 inogadzirwa mumatanho mashanu kubva ku3-Phenylpropionic Acid uye para-Bromoaniline.Kutevera kuumbwa kweamide, kurapwa nePOCl3 uye DMF pasi peVilsmeier-Hack mamiriro akapa 2-Chloroquinoline chigadzirwa.Kurapa nesodium methoxide, kuchiteverwa nekugadzirisa ne3-(Dimethylamino) -1-(naphthalen-1-yl)propan-1-one, uye kupatsanurwa kwemaisomer kwakapa TMC207.

Nyora meseji yako pano uye titumire kwatiri